Millennium Management
PRAX icon

Millennium Management’s Praxis Precision Medicines PRAX Stock Holding History

Millennium Management’s Portfolio PRAX Stock Details PRAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.19M Buy
6,800
+4,200
+162% +$1.3M ﹤0.01% 3791
2025
Q4 		$766K Buy
+2,600
New +$484K ﹤0.01% 4661

Other funds holding PRAX

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

Millennium Management's PRAX Position: Q1 2026 in Review

Millennium Management opened a new position in Praxis Precision Medicines (PRAX) in Q1 2026: 3,831 shares worth $1.23M. The stake represents ﹤0.01% of the portfolio and ranks #4231 among its holdings. This is a return to the name: Millennium Management previously reported a position in PRAX as recently as Q1 2025.

Millennium Management first reported a position in PRAX in Q1 2021 and has held it in 18 quarters since. The position peaked at $11.6M in Q4 2024. 289 funds tracked by Wall St. Rank hold PRAX as of Q1 2026.

  • Millennium Management held 3,831 shares of Praxis Precision Medicines worth $1.23M as of Q1 2026.
  • Praxis Precision Medicines was a new Millennium Management position in Q1 2026.
  • Praxis Precision Medicines made up ﹤0.01% of Millennium Management's portfolio in Q1 2026, its #4231 holding.
  • Millennium Management first reported a position in Praxis Precision Medicines in Q1 2021 and has held it in 18 quarters since.
  • Millennium Management's Praxis Precision Medicines position peaked at $11.6M in Q4 2024.
  • 289 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q1 2026.

Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.